MOPH Announced The Suspension Of Issuance Of Hospitalization Approvals (Visa Cards) For 2 Days

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A03FA01	METORAM	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	3,026,845 L.L
A03FA01	? METOCLOPRAMIDE INJECTION USP	G	Metoclopramide HCl - 10mg/2ml	10mg/2ml	Injectable solution	84,470 L.L
A03FA01	VOMICARE INJECTION BP IM/IV	G	Metoclopramide - 10mg/2ml	10mg/2ml	Injectable solution	247,267 L.L
D02AF	METHYL SALICYLATE COMPOUND UNGUENTUM	G	Methylsalicylate - 4.5g/30g, Menthol - 1.8g/30g		Ointment	165,101 L.L
H02AB04	SOLU MEDROL	B	Methylprednisolone sodium succinate - 500mg	500mg	Injectable powder for solution	718,956 L.L
H02AB04	LISAMETHYLE	G	Methylprednisolone sodium succinate - 40mg/2ml	40mg/2ml	Injectable powder for solution+diluent	7,905,545 L.L
H02AB04	SOLU MEDROL Act-O-Vial	B	Methylprednisolone sodium succinate - 40mg	40mg	Injectable powder for solution+diluent	318,491 L.L
H02AB04	METHYLPREDNISOLONE ORBUCELL INJ.	G	Methylprednisolone sodium succinate - 40mg	40mg	Injectable powder for solution	2,143,749 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 40mg	40mg	Injectable powder for solution	188,138 L.L
H02AB04	SOLU MEDROL	B	Methylprednisolone sodium succinate - 1g	1g	Injectable powder for solution	1,444,631 L.L
H02AB04	METHYLPREDNISOLONE ORBUCELL INJ.	G	Methylprednisolone sodium succinate - 125mg	125mg	Injectable powder for solution	5,784,922 L.L
H02AB04	NEPHARED	G	Methylprednisolone sodium succinate - 125mg	125mg	Injectable powder for solution	469,001 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 80mg/2ml	80mg/2ml	Injectable suspension	365,525 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 40mg/ml	40mg/ml	Injectable suspension	182,763 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Ointment	385,683 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Cream	385,683 L.L
D07AC14	PRENIDERM	G	Methylprednisolone aceponate - 0.1%	0.1%	Cream	312,283 L.L
H02AB04	MP 500	G	Methylprednisolone - 500mg	500mg	Injectable powder for solution	5316240.93 L.L
H02AB04	MP 40	G	Methylprednisolone - 40mg	40mg	Injectable powder for solution	219,046 L.L
H02AB04	METHYL PREDNISOLONE VIATRIS 40MG	G	Methylprednisolone (hemisuccinate) - 40mg	40mg	Injectable dry powder for solution	258,657 L.L
H02AB04	METHYL PREDNISOLONE VIATRIS 1G	G	Methylprednisolone (hemisuccinate) - 1g	1g	Injectable dry powder for solution	1,348,604 L.L
H02AB04	METHYL PREDNISOLONE VIATRIS 120MG	G	Methylprednisolone (hemisuccinate) - 120mg	120mg	Injectable dry powder for solution	602,536 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 54mg	54mg	Tablet, extended release	6,049,979 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 36mg	36mg	Tablet, extended release	4,393,021 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 27mg	27mg	Tablet, extended release	4,393,021 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 18mg	18mg	Tablet, extended release	3,133,841 L.L
N06BA04	RITALIN	B	Methylphenidate HCl - 10mg	10mg	Tablet	376,276 L.L
C02AB02	ALDOMET	B	Methyldopa - 500mg	500mg	Tablet, coated	856,708 L.L
C02AB02	ALDOMET	B	Methyldopa - 250mg	250mg	Tablet, coated	644,400 L.L
N02BG09	PENTHROX INHALER	B	Methoxyflurane -		Inhalation	21,080,096 L.L

MOPH Announced the Suspension of Issuance of Hospitalization Approvals (Visa Cards) for 2 Days